The Chicago Cubs, an American baseball team, has just signed a
33-year-old pitcher with type 1 diabetes for $21 million over two
With the signing, the Cubs indicate that they believe Brandon
Morrow will be a durable anchor for the team's bullpen. He is
currently expected to start the season as the team's closer,
according to a report in the Chicago Tribune.
(A closer is a relief pitcher who specializes in getting the
final runners or batters out in a close game when his team is
leading. The role is often assigned to a team's best reliever.)
The $21 million deal is the largest contract for a professional
athlete with type 1 diabetes since quarterback Jay Cutler signed a
$50 million contract with another Chicago team, the Bears of the
NFL, in 2014.
The $21 million will represent a steep increase in earnings for
Mr Morrow from the minor league deal he had signed with the Los
Angeles Dodgers in the last offseason.
Mr Morrow was once considered one of the most promising young
starting pitchers of Major League Baseball when he started in the
league a decade ago, but his career has been derailed by a series
He began the 2017 season with the Oklahoma City Dodgers (AAA)
before earning his way onto the Dodgers' roster later in the
season. Once in LA, he quickly installed himself as the team's
eighth inning setup man, amassing a stellar 2.06 ERA during the
He added to his great season with a strong performance
throughout three rounds of playoffs, and capped it off by being
only the second pitcher in history to pitch in seven consecutive
games in one World Series.
This will be the fifth Major League team for Mr Morrow, with
previous stops in Seattle, Toronto, and San Diego before Los
In each city he has played, Mr Morrow has raised awareness of
type 1 diabetes and met with young athletes with type 1 diabetes.
He is very open about his condition, and regularly discusses his
blood glucose management strategies with local and national
reporters (he's a pump-wearer, but disconnects when he enters the
The contract guarantees Mr Morrow $18 million for 2018 and 2019.
In 2020, the Chicago Cubs can opt to sign him again for $12
million; if they decline, they will owe him $3 million in a buyout
clause of the contract.
Mr Morrow is one of a small club of players with type 1 diabetes
who have played or are playing in the big leagues. By joining the
Cubs, he follows in the footsteps of Ron Santo, a Hall of Fame
third baseman who played for the Cubs and the crosstown White Sox
in the sixties and seventies. Last year, Dustin McGowan, a former
teammate of Mr Morrow's who also has type 1 diabetes, pitched for
the Miami Marlins.
While Mr Santo was considered a pioneer as a player with type 1
diabetes, advances in management of type 1 diabetes mean it is more
common to find athletes with type 1 diabetes participating in elite